1887

Abstract

The intensified global challenge of antimicrobial resistance, set against the backdrop of the COVID-19 pandemic, is a cause for major concern. Within healthcare settings, intensive care units are recognized as focal points for Gram-negative infections. The study pursued to assess the prevalence and antimicrobial resistance patterns of critical priority pathogens (, , Enterobacteriaceae, comprising and ) during both pre- and COVID-19 periods.

The decision to explore this topic stemmed from the urgent need to understand how the exceptional healthcare crisis of COVID-19 affected AMR patterns.

This was an observational retrospective analysis of 1056 clinical specimens obtained from 950 patients who were admitted to the Medical Intensive Care Unit at Kasr Al-Aini Hospital, Cairo University, Egypt.

In the period before COVID-19, 342 pathogenic isolates (135 . , 83 . , 76 . and 48 ) were obtained from samples collected from 450 patients. Conversely, during the COVID-19 period, 714 isolates (237 . , 205 . , 199 . and 73 ) were collected from the same number of patients. In the course of the pandemic, there is a slight increase in and infections, whereas and exhibit a distinct trend with a noticeable reduction in infection rates during COVID-19. During the COVID-19 period, a noticeable rise in resistance rates was observed for all antibiotics utilized. The results from Fisher’s exact test indicated a substantial increase in resistance towards certain antibiotics. Specifically, a significant rise in resistance was observed for to ciprofloxacin ( = 0.00), gentamicin and ( = 0.02), levofloxacin and ( = 0.01), piperacillin-tazobactam and ( = 0.04), and piperacillin-tazobactam and ( = 0.01).

Our results display how the pandemic impacted bacterial infections and antibiotic resistance, indicating a general increase in resistance rates. These findings are crucial for guiding healthcare practices, emphasizing the need for continued surveillance and potentially checking antibiotic usage schemes.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001838
2024-06-25
2024-07-15
Loading full text...

Full text loading...

References

  1. Salam MA, Al-Amin MY, Salam MT, Pawar JS, Akhter N et al. Antimicrobial resistance: a growing serious threat for global public health. Healthcare 2023; 11:1946 [View Article] [PubMed]
    [Google Scholar]
  2. Helmy YA, Taha-Abdelaziz K, Hawwas HAE-H, Ghosh S, AlKafaas SS et al. Antimicrobial resistance and recent alternatives to antibiotics for the control of bacterial pathogens with an emphasis on foodborne pathogens. Antibiotics 2023; 12:274 [View Article] [PubMed]
    [Google Scholar]
  3. Chinemerem Nwobodo D, Ugwu MC, Oliseloke Anie C, Al-Ouqaili MTS, Chinedu Ikem J et al. Antibiotic resistance: the challenges and some emerging strategies for tackling a global menace. J Clin Lab Anal 2022; 36:e24655 [View Article] [PubMed]
    [Google Scholar]
  4. Abdelaziz AI, Tawfik AG, Rabie KA, Omran M, Hussein M et al. Quality of community pharmacy practice in antibiotic self-medication encounters: a simulated patient study in upper Egypt. Antibiotics 2019; 8:35 [View Article] [PubMed]
    [Google Scholar]
  5. Mogheith AA. The Egyptian national action plan of antimicrobial resistance: governance mechanism and public awareness the American University in Cairo. AUC Knowledge Fountain 2023
    [Google Scholar]
  6. Miethke M, Pieroni M, Weber T, Brönstrup M, Hammann P et al. Towards the sustainable discovery and development of new antibiotics. Nat Rev Chem 2021; 5:726–749 [View Article] [PubMed]
    [Google Scholar]
  7. Naylor NR, Atun R, Zhu N, Kulasabanathan K, Silva S et al. Estimating the burden of antimicrobial resistance: a systematic literature review. Antimicrob Resist Infect Control 2018; 7:58 [View Article] [PubMed]
    [Google Scholar]
  8. Ayukekbong JA, Ntemgwa M, Atabe AN. The threat of antimicrobial resistance in developing countries: causes and control strategies. Antimicrob Resist Infect Control 2017; 6:47 [View Article] [PubMed]
    [Google Scholar]
  9. Mulani MS, Kamble EE, Kumkar SN, Tawre MS, Pardesi KR. Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: a review. Front Microbiol 2019; 10:539 [View Article] [PubMed]
    [Google Scholar]
  10. Organization WH WHO publishes list of bacteria for which new antibiotics are urgently needed; 2017
  11. Haider Qassim Raheem EFH, Ghosh S, Alkafaas SS. Resistance of Klebsiella pneumoniae from different clinical samples to penicillin, Cephalosporin, Carbapenem and Fluoroquinolone. Teikyo Medical J 2021; 44:2693–2700
    [Google Scholar]
  12. Alkafaas SS, Abdallah AM, Hassan MH, Hussien AM, Elkafas SS et al. Molecular docking as a tool for the discovery of novel insight about the role of acid sphingomyelinase inhibitors in SARS- CoV-2 infectivity. BMC Public Health 2024; 24:395 [View Article] [PubMed]
    [Google Scholar]
  13. Alkafaas SS, Abdallah AM, Ghosh S, Loutfy SA, Elkafas SS et al. Insight into the role of clathrin-mediated endocytosis inhibitors in SARS-CoV-2 infection. Rev Med Virol 2023; 33:e2403 [View Article] [PubMed]
    [Google Scholar]
  14. Meskini M, Rezghi Rami M, Maroofi P, Ghosh S, Siadat SD et al. An overview on the epidemiology and immunology of COVID-19. J Infect Public Health 2021; 14:1284–1298 [View Article] [PubMed]
    [Google Scholar]
  15. Rezghi Rami M, Meskini M, Rezaei Khozani N, Forouzandehdel S, Momtaz S et al. Therapeutic potentials and candidates for COVID-19. Iran J Sci 2023; 47:1283–1297 [View Article]
    [Google Scholar]
  16. Ghosh S, Bornman C, Zafer MM. Antimicrobial resistance threats in the emerging COVID-19 pandemic: where do we stand?. J Infect Public Health 2021; 14:555–560 [View Article] [PubMed]
    [Google Scholar]
  17. Ahmadipour M, Dehghan M, Ahmadinejad M, Jabarpour M, Mangolian Shahrbabaki P et al. Barriers to hand hygiene compliance in intensive care units during the COVID-19 pandemic: a qualitative study. Front Public Health 2022; 10:968231 [View Article] [PubMed]
    [Google Scholar]
  18. Jorgensen JH, Pfaller MA, Carroll KC. American Society for M Manual of Clinical Microbiology, 11th edn Washington, DC: ASM Press Washington, DC; 2015
    [Google Scholar]
  19. Quinn PJ, Markey BK, Leonard FC, Hartigan P et al. Veterinary Microbiology and Microbial Disease, 2nd edn Wiley-Blackwell; 2011
    [Google Scholar]
  20. CLSI Autoverification of Medical Laboratory Results for Specific Disciplines, 1st edn Clinical and Laboratory Standards Institute; 2019
    [Google Scholar]
  21. CLSI Autoverification of Medical Laboratory Results for Specific Disciplines, 1st edn Clinical and Laboratory Standards Institute; 2020
    [Google Scholar]
  22. Computing RFfS R: a language and environment for statistical computing version 4.3.2. R Foundation for Statistical Computing, Vienna, Austria; 2023 https://www.R-project.org
  23. Hadley W, Houck CD, Barker DH, Bogner J, Franz D. Using virtual reality to examine the association between respiratory sinus arrhythmia and adolescent substance use. Child Psychiatry Hum Dev 2023; 54:1055–1063 [View Article] [PubMed]
    [Google Scholar]
  24. Fisher RA. On the interpretation of χ2 from contingency tables, and the calculation of P. J R Stat Soc 1922; 85:87 [View Article]
    [Google Scholar]
  25. Hadley W, Romain F, Lionel H, Kirill M, Davis V. dplyr: a grammar of data manipulation; 2023 https://dplyr.tidyverse.org
  26. Philipp S, Alexander W. openxlsx: read, write and edit xlsx files; 2022 https://github.com/ycphs/openxlsx
  27. H W, D V, M G tidyr: Tidy Messy Data; 2023 https://tidyr.tidyverse.org
  28. Wickham H. ggplot2. In Ggplot2: Elegant Graphics for Data Analysis Cham: Springer International Publishing; 2016 [View Article]
    [Google Scholar]
  29. Raivo K. pheatmap: pretty heatmaps; 2019 https://github.com/raivokolde/pheatmap
  30. Hadley W. Reshaping data with the {reshape} package. J Stat Softw 2007
    [Google Scholar]
  31. Bizri AR, El-Fattah AA, Bazaraa HM, Al Ramahi JW, Matar M et al. Antimicrobial resistance landscape and COVID-19 impact in Egypt, Iraq, Jordan, and Lebanon: a survey-based study and expert opinion. PLoS One 2023; 18:e0288550 [View Article] [PubMed]
    [Google Scholar]
  32. Zafer MM, Al-Agamy MH, El-Mahallawy HA, Amin MA, Ashour M-D. Antimicrobial resistance pattern and their beta-lactamase encoding genes among Pseudomonas aeruginosa strains isolated from cancer patients. Biomed Res Int 2014; 2014:101635 [View Article] [PubMed]
    [Google Scholar]
  33. ElMahallawy H, Zafer MM, Al-Agamy M, Amin MA, Mersal MM et al. Dissemination of ST101 blaOXA-48 producing Klebsiella pneumoniae at tertiary care setting. J Infect Dev Ctries 2018; 12:422–428 [View Article] [PubMed]
    [Google Scholar]
  34. El-Mahallawy HA, El Swify M, Abdul Hak A, Zafer MM. Increasing trends of colistin resistance in patients at high-risk of carbapenem-resistant Enterobacteriaceae. Ann Med 2022; 54:1–9 [View Article] [PubMed]
    [Google Scholar]
  35. Hamed SM, Hussein AFA, Al-Agamy MH, Radwan HH, Zafer MM. Genetic configuration of genomic resistance islands in Acinetobacter baumannii clinical isolates from Egypt. Front Microbiol 2022; 13:878912 [View Article] [PubMed]
    [Google Scholar]
  36. Zafer MM, El-Mahallawy HA, Ashour HM. Severe COVID-19 and sepsis: immune pathogenesis and laboratory markers. Microorganisms 2021; 9:159 [View Article] [PubMed]
    [Google Scholar]
  37. Rahman A, Niloofa R, Jayarajah U, De Mel S, Abeysuriya V et al. Hematological abnormalities in COVID-19: a narrative review. Am J Trop Med Hyg 2021; 104:1188–1201 [View Article] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.001838
Loading
/content/journal/jmm/10.1099/jmm.0.001838
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error